id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-1975-0002,FDA,FDA-1978-N-1975,Hematology and Pathology Devices Classification of Red Cell Lysing Reagents,Rule,Final Rule,2012-07-27T04:00:00Z,2012,7,2012-07-27T04:00:00Z,1980-10-15T03:59:59Z,2012-07-27T12:55:52Z,,0,0,09000064805a1aae
FDA-1978-N-1975-0003,FDA,FDA-1978-N-1975,"Accession No 88-86-05, Box 11 Retired",Other,Retired (RET),2012-07-27T04:00:00Z,2012,7,2012-07-27T04:00:00Z,,2012-07-27T12:55:52Z,,0,0,09000064805a1aaf
FDA-1978-N-1975-0001,FDA,FDA-1978-N-1975,Medical Devices Classification of Red Cell Lysing Reagents,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-06-25T04:00:00Z,2012,6,2012-06-25T04:00:00Z,1979-11-14T04:59:59Z,2012-06-25T18:19:43Z,,0,0,09000064805a1aaa